牛牛AI助理已提取核心訊息
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
T2 Biosystems, Inc.（TTOO）總法律顧問邁克爾·特倫斯·吉布斯於2024年2月24日執行了一項交易，涉及收購29股普通股。該交易被歸類爲'M'，表示行使或轉換衍生證券。在這筆交易之後，吉布斯直接持有該公司總共135股股份。股份的性質是直接的，表示吉布斯的個人所有權。
T2 Biosystems, Inc.（TTOO）總法律顧問邁克爾·特倫斯·吉布斯於2024年2月24日執行了一項交易，涉及收購29股普通股。該交易被歸類爲'M'，表示行使或轉換衍生證券。在這筆交易之後，吉布斯直接持有該公司總共135股股份。股份的性質是直接的，表示吉布斯的個人所有權。
有用
沒用